-
Immuneering (NASDAQ:IMRX) Given "Buy" Rating at Chardan Capital
ソース: Buzz FX / 08 1 2025 08:26:15 America/New_York
Immuneering (NASDAQ:IMRX) Given "Buy" Rating at Chardan Capital Written by MarketBeat January 8, 2025 Share Link copied to clipboard. Immuneering ( NASDAQ:IMRX - Get Free Report ) 's stock had its "buy" rating reaffirmed by research analyst
Read more...